NRx Pharmaceuticals

NRx Pharmaceuticals Completes Enrollment in Pivotal Trial for Suicidal Bipolar Depression Treatment

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a Pennsylvania-based biopharmaceutical company, recently announced it has completed enrollment for its Phase 2b/3 study of NRX-101. This patented combination of D-cycloserine, …

NRx Pharmaceuticals Completes Enrollment in Pivotal Trial for Suicidal Bipolar Depression Treatment Read More


Windtree Therapeutics

Windtree Therapeutics Makes Strategic Move to Bolster Balance Sheet, Hints at Brighter Prospects

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology firm specializing in developing novel therapeutics for acute pulmonary and cardiovascular diseases, has made a strategic move that could enhance …

Windtree Therapeutics Makes Strategic Move to Bolster Balance Sheet, Hints at Brighter Prospects Read More

Carpenter Technology Corporation

Carpenter Technology: Q2 FY2024 Financials Surpass Expectations – On Track for Record Profitability

PHILADELPHIA, PA — Carpenter Technology Corporation (NYSE: CRS), a recognized pioneer in high-performance specialty alloy-based materials and process solutions, recently announced its financial results for the second quarter of fiscal …

Carpenter Technology: Q2 FY2024 Financials Surpass Expectations – On Track for Record Profitability Read More